Fibroheal raises Rs 14 Cr to expand advanced wound care technology

Bengaluru-based Fibroheal Woundcare has successfully raised Rs 14 crore in fresh capital to accelerate its next phase of growth and expand into developed global markets.

Founded with a vision to transform wound care through silk protein-based biomaterial innovations, Fibroheal has emerged as one of India's promising MedTech companies. The fresh investment will enable the company to strengthen its commercial capabilities, expand internationally, and accelerate the development of breakthrough biomaterial-based healthcare solutions.

This milestone reflects not only the confidence of its investors but also the strength of India's innovation ecosystem in creating globally competitive healthcare technologies. With plans to enter developed markets and launch next-generation biomaterial products, Fibroheal is well positioned to make a significant global impact in the MedTech sector.

The company is working towards bringing two game changing products – Fibroplug ORC – a bioresorbable material to arrest internal bleeding post surgeries; and a bone regenerative solution for infected bone injuries and other complex orthopaedic recoveries and is expected to launch in FY 2027.